메뉴 건너뛰기




Volumn 7, Issue 1, 2017, Pages

Targeted inhibition of RAGE in substantia nigra of rats blocks 6-OHDA-induced dopaminergic denervation

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AUTACOID; CYTOKINE; DOPAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOPAMINE; PROTEIN TYROSINE KINASE;

EID: 85027843681     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-09257-3     Document Type: Article
Times cited : (40)

References (34)
  • 1
    • 84944044033 scopus 로고    scopus 로고
    • Neuroinflammation in Parkinson's disease and its potential as therapeutic target
    • Wang, Q., Liu, Y. & Zhou, J. Neuroinflammation in Parkinson's disease and its potential as therapeutic target. Transl Neurodegener 4, doi:10.1186/s40035-015-0042-0 (2015).
    • (2015) Transl Neurodegener , vol.4
    • Wang, Q.1    Liu, Y.2    Zhou, J.3
  • 2
    • 84954039309 scopus 로고    scopus 로고
    • Receptor for advanced glycation end products and its inflammatory ligands are upregulated in amyotrophic lateral sclerosis
    • Juranek, J. K. et al. Receptor for Advanced Glycation End Products and its Inflammatory Ligands are Upregulated in Amyotrophic Lateral Sclerosis. Front Cell Neurosci 9, doi:10.3389/fncel.2015.00485 (2015).
    • (2015) Front Cell Neurosci , vol.9
    • Juranek, J.K.1
  • 3
    • 84859723641 scopus 로고    scopus 로고
    • A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease
    • Deane, R. et al. A multimodal RAGE-specific inhibitor reduces amyloid beta-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 122, 1377-1392, doi:10.1172/jci58642 (2012).
    • (2012) J Clin Invest , vol.122 , pp. 1377-1392
    • Deane, R.1
  • 4
    • 84864379214 scopus 로고    scopus 로고
    • Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
    • Teismann, P. et al. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity. Neurobiology of aging 33, 2478-2490, doi:10.1016/j.neurobiolaging.2011.12.006 (2012).
    • (2012) Neurobiology of Aging , vol.33 , pp. 2478-2490
    • Teismann, P.1
  • 5
    • 84978993731 scopus 로고    scopus 로고
    • Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease
    • De Jesus-Cortes, H. et al. Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease. NPJ Parkinsons Dis 1, doi:10.1038/npjparkd.2015.10 (2015).
    • (2015) NPJ Parkinsons Dis , vol.1
    • De Jesus-Cortes, H.1
  • 6
    • 84857869793 scopus 로고    scopus 로고
    • Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease
    • Thiele, S. L., Warre, R. & Nash, J. E. Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson's disease. J Vis Exp. doi:10.3791/3234 (2012).
    • (2012) J Vis Exp.
    • Thiele, S.L.1    Warre, R.2    Nash, J.E.3
  • 7
    • 84953287235 scopus 로고    scopus 로고
    • Effects of RAGE-specific inhibitor FPS-ZM1 on amyloid-beta metabolism and AGEs-induced inflammation and oxidative stress in rat hippocampus
    • Hong, Y. et al. Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-beta Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus. Neurochem Res 41, 1192-1199, doi:10.1007/s11064-015-1814-8 (2016).
    • (2016) Neurochem Res , vol.41 , pp. 1192-1199
    • Hong, Y.1
  • 8
    • 84933528303 scopus 로고    scopus 로고
    • Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage
    • Yang, F. et al. Receptor for advanced glycation end-product antagonist reduces blood-brain barrier damage after intracerebral hemorrhage. Stroke 46, 1328-1336, doi:10.1161/strokeaha.114.008336 (2015).
    • (2015) Stroke , vol.46 , pp. 1328-1336
    • Yang, F.1
  • 9
    • 42549135904 scopus 로고    scopus 로고
    • Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease
    • Maczurek, A., Shanmugam, K. & Munch, G. Inflammation and the redox-sensitive AGE-RAGE pathway as a therapeutic target in Alzheimer's disease. Annals of the New York Academy of Sciences 1126, 147-151, doi:10.1196/annals.1433.026 (2008).
    • (2008) Annals of the New York Academy of Sciences , vol.1126 , pp. 147-151
    • Maczurek, A.1    Shanmugam, K.2    Munch, G.3
  • 10
    • 84881118554 scopus 로고    scopus 로고
    • Cellular signalling of the receptor for advanced glycation end products (RAGE)
    • Xie, J., Mendez, J. D., Mendez-Valenzuela, V. & Aguilar-Hernandez, M. M. Cellular signalling of the receptor for advanced glycation end products (RAGE). Cellular signalling 25, 2185-2197, doi:10.1016/j.cellsig.2013.06.013 (2013).
    • (2013) Cellular Signalling , vol.25 , pp. 2185-2197
    • Xie, J.1    Mendez, J.D.2    Mendez-Valenzuela, V.3    Aguilar-Hernandez, M.M.4
  • 11
    • 84920609361 scopus 로고    scopus 로고
    • Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress
    • Tobon-Velasco, J. C., Cuevas, E. & Torres-Ramos, M. A. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS & neurological disorders drug targets 13, 1615-1626 (2014).
    • (2014) CNS & Neurological Disorders Drug Targets , vol.13 , pp. 1615-1626
    • Tobon-Velasco, J.C.1    Cuevas, E.2    Torres-Ramos, M.A.3
  • 13
    • 77953800114 scopus 로고    scopus 로고
    • Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease
    • Grealish, S., Mattsson, B., Draxler, P. & Bjorklund, A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. Eur J Neurosci 31, 2266-2278, doi:10.1111/j.1460-9568.2010.07265.x (2010).
    • (2010) Eur J Neurosci , vol.31 , pp. 2266-2278
    • Grealish, S.1    Mattsson, B.2    Draxler, P.3    Bjorklund, A.4
  • 14
    • 34548458484 scopus 로고    scopus 로고
    • The 6-hydroxydopamine model of Parkinson's disease
    • Simola, N., Morelli, M. & Carta, A. R. The 6-hydroxydopamine model of Parkinson's disease. Neurotox Res 11, 151-167 (2007).
    • (2007) Neurotox Res , vol.11 , pp. 151-167
    • Simola, N.1    Morelli, M.2    Carta, A.R.3
  • 15
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer, W. & Przedborski, S. Parkinson's disease: mechanisms and models. Neuron 39, 889-909 (2003).
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 16
    • 84903782549 scopus 로고    scopus 로고
    • Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury
    • Zhang, H. et al. Genetic deficiency of neuronal RAGE protects against AGE-induced synaptic injury. Cell death & disease 5, e1288, doi:10.1038/cddis.2014.248 (2014).
    • (2014) Cell Death & Disease , vol.5 , pp. e1288
    • Zhang, H.1
  • 17
    • 84953931462 scopus 로고    scopus 로고
    • RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis
    • Ray, R., Juranek, J. K. & Rai, V. RAGE axis in neuroinflammation, neurodegeneration and its emerging role in the pathogenesis of amyotrophic lateral sclerosis. Neuroscience and biobehavioral reviews 62, 48-55, doi:10.1016/j.neubiorev.2015.12.006 (2016).
    • (2016) Neuroscience and Biobehavioral Reviews , vol.62 , pp. 48-55
    • Ray, R.1    Juranek, J.K.2    Rai, V.3
  • 18
    • 0034798997 scopus 로고    scopus 로고
    • Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins
    • Safavi-Abbasi, S., Wolff, J. R. & Missler, M. Rapid morphological changes in astrocytes are accompanied by redistribution but not by quantitative changes of cytoskeletal proteins. Glia 36, 102-115 (2001).
    • (2001) Glia , vol.36 , pp. 102-115
    • Safavi-Abbasi, S.1    Wolff, J.R.2    Missler, M.3
  • 19
    • 84946401009 scopus 로고    scopus 로고
    • Altered morphological dynamics of activated microglia after induction of status epilepticus
    • Avignone, E., Lepleux, M., Angibaud, J. & Nägerl, U. V. Altered morphological dynamics of activated microglia after induction of status epilepticus. J Neuroinflammation 12, doi:10.1186/s12974-015-0421-6 (2015).
    • (2015) J Neuroinflammation , vol.12
    • Avignone, E.1    Lepleux, M.2    Angibaud, J.3    Nägerl, U.V.4
  • 20
    • 84878897062 scopus 로고    scopus 로고
    • Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats
    • Healy-Stoffel, M., Ahmad, S. O. & Stanford, J. A. & Levant, B. Altered nucleolar morphology in substantia nigra dopamine neurons following 6-hydroxydopamine lesion in rats. Neurosci Lett 546, 26-30, doi:10.1016/j.neulet.2013.04.033 (2013).
    • (2013) Neurosci Lett , vol.546 , pp. 26-30
    • Healy-Stoffel, M.1    Ahmad, S.O.2    Stanford, J.A.3    Levant, B.4
  • 21
    • 26444478269 scopus 로고    scopus 로고
    • Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation
    • Ramasamy, R. et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16r-28r, doi:10.1093/glycob/cwi053 (2005).
    • (2005) Glycobiology , vol.15 , pp. 16-28
    • Ramasamy, R.1
  • 22
    • 0030910830 scopus 로고    scopus 로고
    • Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products
    • Li, J. & Schmidt, A. M. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. The Journal of biological chemistry 272, 16498-16506 (1997).
    • (1997) The Journal of Biological Chemistry , vol.272 , pp. 16498-16506
    • Li, J.1    Schmidt, A.M.2
  • 23
    • 0142039004 scopus 로고    scopus 로고
    • The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
    • Ishihara, K., Tsutsumi, K., Kawane, S., Nakajima, M. & Kasaoka, T. The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site. FEBS letters 550, 107-113 (2003).
    • (2003) FEBS Letters , vol.550 , pp. 107-113
    • Ishihara, K.1    Tsutsumi, K.2    Kawane, S.3    Nakajima, M.4    Kasaoka, T.5
  • 24
    • 84870168829 scopus 로고    scopus 로고
    • S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway
    • Sathe, K. et al. S100B is increased in Parkinson's disease and ablation protects against MPTP-induced toxicity through the RAGE and TNF-alpha pathway. Brain: a journal of neurology 135, 3336-3347, doi:10.1093/brain/aws250 (2012).
    • (2012) Brain: A Journal of Neurology , vol.135 , pp. 3336-3347
    • Sathe, K.1
  • 25
    • 84962520475 scopus 로고    scopus 로고
    • In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin
    • Santoro, M. et al. In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin. Neurobiol Dis 91, 59-68, doi:10.1016/j. nbd.2016.02.018 (2016).
    • (2016) Neurobiol Dis , vol.91 , pp. 59-68
    • Santoro, M.1
  • 26
    • 77955057715 scopus 로고    scopus 로고
    • Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
    • Santiago, R. M. et al. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Progress in neuro-psychopharmacology & biological psychiatry 34, 1104-1114, doi:10.1016/j.pnpbp.2010.06.004 (2010).
    • (2010) Progress in Neuro-psychopharmacology & Biological Psychiatry , vol.34 , pp. 1104-1114
    • Santiago, R.M.1
  • 27
    • 84945275413 scopus 로고
    • National Institutes of Health Guide for Careand Use of Laboratory Animals. Accessed 15 Jan 2017
    • National Institutes of Health Guide for Careand Use of Laboratory Animals. Eighth Edition. Avaiable in https://grants.nih.gov/grants/olaw/Guide-for-the-Care-and-Use-of-Laboratory-Animals.pdf Accessed 15 Jan 2017 (1985).
    • (1985) Eighth Edition
  • 28
    • 84862571593 scopus 로고    scopus 로고
    • Motor and non-motor features of Parkinson's disease - A review of clinical and experimental studies
    • Lima, M. M. et al. Motor and non-motor features of Parkinson's disease - a review of clinical and experimental studies. CNS & neurological disorders drug targets 11, 439-449 (2012).
    • (2012) CNS & Neurological Disorders Drug Targets , vol.11 , pp. 439-449
    • Lima, M.M.1
  • 30
    • 84919413546 scopus 로고    scopus 로고
    • Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with leishmania amazonensis
    • Gasparotto, J. et al. Increased tau phosphorylation and receptor for advanced glycation endproducts (RAGE) in the brain of mice infected with Leishmania amazonensis. Brain Behav Immun 43, 37-45, doi:10.1016/j.bbi.2014.06.204 (2015).
    • (2015) Brain Behav Immun , vol.43 , pp. 37-45
    • Gasparotto, J.1
  • 31
    • 84879063079 scopus 로고    scopus 로고
    • Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats
    • Colle, D. et al. Probucol Increases Striatal Glutathione Peroxidase Activity and Protects against 3-Nitropropionic Acid-Induced Pro-Oxidative Damage in Rats. PLoS One 8, doi:10.1371/journal.pone.0067658 (2013).
    • (2013) PLoS One , vol.8
    • Colle, D.1
  • 32
    • 84923319244 scopus 로고    scopus 로고
    • A partial lesion model of Parkinson's disease in mice-characterization of a 6-OHDA-induced medial forebrain bundle lesion
    • Boix, J., Padel, T. & Paul, G. A partial lesion model of Parkinson's disease in mice-characterization of a 6-OHDA-induced medial forebrain bundle lesion. Behav Brain Res 284, 196-206, doi:10.1016/j.bbr.2015.01.053 (2015).
    • (2015) Behav Brain Res , vol.284 , pp. 196-206
    • Boix, J.1    Padel, T.2    Paul, G.3
  • 33
    • 0033950675 scopus 로고    scopus 로고
    • CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury
    • Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L. & Bland, S. T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 39, 777-787 (2000).
    • (2000) Neuropharmacology , vol.39 , pp. 777-787
    • Schallert, T.1    Fleming, S.M.2    Leasure, J.L.3    Tillerson, J.L.4    Bland, S.T.5
  • 34
    • 0017184389 scopus 로고
    • A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
    • Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254 (1976).
    • (1976) Anal Biochem , vol.72 , pp. 248-254
    • Bradford, M.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.